Pneumococcal vaccination and risk of myocardial infarction

CMAJ. Canadian Medical Association Journal

Volumn 179, Issue 8, 2008, Pages 773-777

  Lamontagne, François ^a,b   Garant, Marie Pierre ^a   Carvalho, Jean Christophe ^a   Lanthier, Luc ^a   Smieja, Marek ^b   Pilon, Danielle ^a,c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART PROTECTION; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; SEX RATIO; SPLENECTOMY; STREPTOCOCCUS PNEUMONIA; VACCINATION;

EID: 54349104894     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.070221     Document Type: Article

References (18)

1. Martin GM. Atherosclerosis is the leading cause of death in the developed societies. Am J Pathol 1998;153:1319-20.
2. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-5.
3. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000;75:369-80.
4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
5. Schönbeck U, Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004;109(Suppl 1):II18-26.
6. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003;9:736-43.
7. Robinette CD, Fraumeni JF Jr. Splenectomy and subsequent mortality in veterans of the 1939-45 war. Lancet 1977;2:127-9.
8. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-8.
9. Grant A, Moshyk A, Diab H, et al. Integrating feedback from a clinical data warehouse into practice organisation. Int J Med Inform 2006;75:232-9.
10. Brophy JM, Brassard P, Bourgault C. The benefit of cholesterol-lowering medications after coronary revascularization: a population study. Am Heart J 2005;150:282-6.
11. Lachaine J, Rinfret S, Merikle EP, et al. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'assurance maladie du Québec data. Am Heart J 2006;152:164-9.
12. Rahme E, Toubouti Y, Hunsche E. Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada. Rheumatology (Oxford) 2006;45:903-10.
13. Cannon CP, Braunwald E, McCabe CH, et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005;352:1646-54.
14. Cercek B, Shah PK, Noc M, et al. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003;361:809-13.
15. Grayston JT, Kronmal RA, Jackson LA, et al. Azithromycin for the secondary prevention of coronary events. N Engl J Med 2005;352:1637-45.
16. O'Connor CM, Dunne MW, Pfeffer MA, et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 2003;290:1459-66.
17. Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001;103:45-51.
18. Zhu J, Quyyumi AA, Norman JE, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000;85:140-6.